https://pharmadog.xyz/news/633219 pharmadog en 2026-11-03T18:44:00.000Z Live discussion to assess how US midterm elections could reshape biopharma policy https://pharmadog.xyz/news/633115 pharmadog en 2026-11-03T17:32:00.000Z Vertex, ahead of FDA decision, calms fears surrounding kidney drug https://pharmadog.xyz/news/632799 pharmadog en 2026-11-03T16:25:38.000Z Compass Pathways to file FDA approval for psilocybin depression therapy within weeks https://pharmadog.xyz/news/632607 pharmadog en 2026-11-03T15:37:30.000Z Endpoints Announces Second Annual Health Tech Day with Virtual Sessions https://pharmadog.xyz/news/632651 pharmadog en 2026-11-03T15:36:21.000Z Compass Pathways leads race for first psychedelic drug approval, non-profit rivals https://pharmadog.xyz/news/632652 pharmadog en 2026-11-03T15:29:07.000Z Midterm elections could reshape health policy, Medicare Advantage and insurance, STAT analysis says https://pharmadog.xyz/news/632631 pharmadog en 2026-11-03T15:15:02.000Z Lonza to acquire five Merck KGaA US facilities, more than doubling its US footprint https://pharmadog.xyz/news/632608 pharmadog en 2026-11-03T15:04:17.000Z Pfizer raises 2026 outlook as oncology and migraine growth balances Covid product decline https://pharmadog.xyz/news/632439 pharmadog en 2026-11-03T14:56:47.000Z Novartis ends discovery-stage collaboration with BioArctic amid broader biotech updates https://pharmadog.xyz/news/632483 pharmadog en 2026-11-03T14:51:12.000Z FDA and CMS seek state partnerships to shape health AI regulations and liability protections https://pharmadog.xyz/news/632484 pharmadog en 2026-11-03T14:44:54.000Z FDA grants tentative approval for Dr. Reddy’s generic HIV prevention shot, expanding access in low- and middle-income countries https://pharmadog.xyz/news/632463 pharmadog en 2026-11-03T14:29:01.000Z Neurocrine launches new safety study after another death linked to Prader-Willi drug Vykat https://pharmadog.xyz/news/632464 pharmadog en 2026-11-03T14:08:49.000Z Novartis ends $772M BioArctic brain-delivery partnership https://pharmadog.xyz/news/632295 pharmadog en 2026-11-03T13:53:39.000Z Pfizer reports flat Q3 revenue as non-COVID sales rise 7% and acquired products grow 32% https://pharmadog.xyz/news/632315 pharmadog en 2026-11-03T13:48:16.000Z New York records first measles death in three decades as vaccination rates slip https://pharmadog.xyz/news/632335 pharmadog en 2026-11-03T13:46:00.000Z Medicare Part D premiums expected to rise 50% on average in 2027, KFF warns seniors to compare plans https://pharmadog.xyz/news/632504 pharmadog en 2026-11-03T13:41:00.000Z UniQure slated for FDA decision by May 1 as analysts see potential for first Huntington’s disease therapy https://pharmadog.xyz/news/632147 pharmadog en 2026-11-03T12:52:30.000Z First U.S. bird flu death of 2026 reported in Washington state after cattle exposure https://pharmadog.xyz/news/632103 pharmadog en 2026-11-03T12:01:37.000Z Bayer CEO says company is negotiating a most-favored-nation trade pact with US administration https://pharmadog.xyz/news/631599 pharmadog en 2026-11-03T09:54:12.000Z Merck KGaA sells its CDMO business and US sites to Lonza https://pharmadog.xyz/news/632583 pharmadog en 2026-11-03T09:35:00.000Z Rhythm Pharmaceuticals expands LG Chem obesity drug license, total payout up to $855 million https://pharmadog.xyz/news/631643 pharmadog en 2026-11-03T09:30:00.000Z Mortality rates remain higher in states that supported Trump, highlighting political health divide in 2024 https://pharmadog.xyz/news/631644 pharmadog en 2026-11-03T09:30:00.000Z Physician finds meditation boosts resilience and patient care after intense trauma cases https://pharmadog.xyz/news/631645 pharmadog en 2026-11-03T09:30:00.000Z Scientists question safety and benefits of three-parent IVF as new UK data raise concerns https://pharmadog.xyz/news/632414 pharmadog en 2026-11-03T08:41:00.000Z AbbVie halts development of livmoniplimab after deeming benefit limited https://pharmadog.xyz/news/632415 pharmadog en 2026-11-03T08:29:00.000Z Pfizer drops phase 2 pulmonary arterial hypertension candidate amid pipeline cut https://pharmadog.xyz/news/632582 pharmadog en 2026-11-03T05:05:00.000Z Philips earmarks $322 million for pending DOJ settlement on sleep-apnea device recall https://pharmadog.xyz/news/631742 pharmadog en 2026-11-03T04:55:00.000Z Novartis ends $800M neuroscience partnership with BioArctic after 14 months https://pharmadog.xyz/news/632754 pharmadog en 2026-11-03T04:09:00.000Z Abbott reports 30‑day success in Tectonic trial of SonicForce coronary IVL system https://pharmadog.xyz/news/629391 pharmadog en 2026-11-02T21:03:38.000Z Karyopharm files for Chapter 11 bankruptcy as it pursues merger with Ayrmid https://pharmadog.xyz/news/629243 pharmadog en 2026-11-02T20:44:40.000Z Washington resident dies after bird flu infection linked to dairy cattle exposure https://pharmadog.xyz/news/629031 pharmadog en 2026-11-02T19:43:03.000Z AbbVie signs up to $757M deal with Beijing's Brise Pharma for two preclinical migraine candidates https://pharmadog.xyz/news/628755 pharmadog en 2026-11-02T18:44:22.000Z WuXi Biologics and Fresenius strike major deal for up to 37 biosimilars over the next decade https://pharmadog.xyz/news/633174 pharmadog en 2026-11-02T17:19:00.000Z Brad's Raw Chips recalls kale chips over potential thallium contamination https://pharmadog.xyz/news/628611 pharmadog en 2026-11-02T17:15:16.000Z FDA policy allowing compounding of unapproved peptides raises safety and development concerns https://pharmadog.xyz/news/628651 pharmadog en 2026-11-02T17:07:00.000Z Karyopharm files for Chapter 11 and plans auction with Gamida Cell parent Ayrmid as lead bidder https://pharmadog.xyz/news/628631 pharmadog en 2026-11-02T17:05:28.000Z Midterm voters weigh health-care costs as urgent-care visits billed like ERs https://pharmadog.xyz/news/628443 pharmadog en 2026-11-02T16:52:45.000Z Sun Pharma halts eye-care drug production in India after regulator cited quality failures https://pharmadog.xyz/news/628463 pharmadog en 2026-11-02T16:47:33.000Z Study finds psilocybin does not produce lasting anxiety or depression relief in mice https://pharmadog.xyz/news/628464 pharmadog en 2026-11-02T16:13:46.000Z FDA grants tentative approval for generic HIV prevention shot, boosting access in low-income nations https://pharmadog.xyz/news/628419 pharmadog en 2026-11-02T16:10:20.000Z FDA sets May 1 decision deadline for UniQure’s Huntington’s disease gene therapy after advisory committee meeting https://pharmadog.xyz/news/628251 pharmadog en 2026-11-02T15:28:10.000Z Karyopharm Therapeutics to merge with Ayrmid as it enters bankruptcy https://pharmadog.xyz/news/629342 pharmadog en 2026-11-02T15:28:00.000Z FDA places uniQure’s Huntington’s gene therapy in priority review, targeting May 2027 approval https://pharmadog.xyz/news/628275 pharmadog en 2026-11-02T15:16:02.000Z Tiziana's lower-dose foralumab cuts neuroinflammation in SPMS, but higher dose fails https://pharmadog.xyz/news/628252 pharmadog en 2026-11-02T15:11:58.000Z FDA places Bright Minds seizure drug BMB-101 on partial hold over mouse toxicity, shares plunge https://pharmadog.xyz/news/134233 pharmadog en 2026-11-02T15:08:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/628277 pharmadog en 2026-11-02T15:03:52.000Z Cell and gene therapy funding climbs to $2.2 billion in Q3 despite safety setbacks in CAR-T trials https://pharmadog.xyz/news/628107 pharmadog en 2026-11-02T14:41:57.000Z U.S. bioscience jobs up 7% from 2021 to 2025: Report https://pharmadog.xyz/news/628147 pharmadog en 2026-11-02T14:34:00.000Z FDA accepts first Keytruda biosimilar application as Merck faces looming patent cliff https://pharmadog.xyz/news/628108 pharmadog en 2026-11-02T14:32:20.000Z FDA sets May 1 decision date for uniQure's Huntington's disease gene therapy after year-long regulatory saga https://pharmadog.xyz/news/628127 pharmadog en 2026-11-02T14:22:08.000Z Four major drugmakers allegedly paid tens of millions to Russian middlemen for lifesaving drugs, limiting patient access https://pharmadog.xyz/news/628148 pharmadog en 2026-11-02T14:00:00.000Z AstraZeneca outlines restructuring as earnings show cost cuts, while Alnylam slides and Regeneron posts record quarter https://pharmadog.xyz/news/628166 pharmadog en 2026-11-02T13:56:06.000Z FDA issues final guidance on potency assurance for cell and gene therapy manufacturers https://pharmadog.xyz/news/627959 pharmadog en 2026-11-02T13:08:42.000Z Woman travels to Albania for experimental mitochondrial replacement therapy amid global fertility industry concerns https://pharmadog.xyz/news/627771 pharmadog en 2026-11-02T12:28:16.000Z FDA accepts review of Biohaven’s ataxia drug, boosting shares as ArriVent’s lung cancer trial miss drags its stock down https://pharmadog.xyz/news/627747 pharmadog en 2026-11-02T12:00:45.000Z CinRx partners with Graviton Bioscience to target ROCK2 in pulmonary arterial hypertension and other cardiovascular diseases https://pharmadog.xyz/news/628226 pharmadog en 2026-11-02T10:17:00.000Z Karyopharm files Chapter 11 and taps Irish biotech Ayrmid as lead bidder for merger https://pharmadog.xyz/news/627307 pharmadog en 2026-11-02T10:00:00.000Z Pharma leaders turn to integrated scenario modeling as US MFN pricing reshapes global launch strategies https://pharmadog.xyz/news/628395 pharmadog en 2026-11-02T09:55:00.000Z Biossil Labs acquires Theriva's antibiotic-degrader portfolio in up to $91 million deal https://pharmadog.xyz/news/627290 pharmadog en 2026-11-02T09:30:00.000Z U.S. Health Care System's Economics Are Broken, Says Ascendiun CEO https://pharmadog.xyz/news/627291 pharmadog en 2026-11-02T09:30:00.000Z Women travel abroad for unproven three-parent IVF marketed to older patients https://pharmadog.xyz/news/627287 pharmadog en 2026-11-02T09:30:00.000Z STAT calls for input on mitochondrial replacement therapy used in fertility tourism https://pharmadog.xyz/news/627288 pharmadog en 2026-11-02T09:30:00.000Z Kymera Therapeutics to unveil mid‑stage eczema trial data, aiming to challenge Dupixent https://pharmadog.xyz/news/627289 pharmadog en 2026-11-02T09:30:00.000Z Cancer can be treated safely during pregnancy, says maternal-fetal specialist https://pharmadog.xyz/news/628058 pharmadog en 2026-11-02T09:24:00.000Z Teva halts phase 2 trial of emrusolmin for multiple system atrophy after futility analysis https://pharmadog.xyz/news/627890 pharmadog en 2026-11-02T08:43:00.000Z FDA places partial hold on Bright Minds' seizure trial over mouse toxicity concerns https://pharmadog.xyz/news/628060 pharmadog en 2026-11-02T08:40:00.000Z Tiziana's intranasal MS drug shows lower dose cuts neuroinflammation, higher dose falls short in Phase 2a trial https://pharmadog.xyz/news/626823 pharmadog en 2026-11-02T07:04:00.000Z Top pharma firms line up for Summit Therapeutics' ivonescimab after strong China Phase 3 data https://pharmadog.xyz/news/626824 pharmadog en 2026-11-02T07:00:00.000Z FDA issues draft guidance to streamline approval of personalized gene therapies https://pharmadog.xyz/news/626655 pharmadog en 2026-11-02T06:01:00.000Z Saudi Arabia pushes ahead with biotech hub despite regional instability https://pharmadog.xyz/news/627554 pharmadog en 2026-11-02T05:47:00.000Z InventisBio's Phase 3 Trial Shows Nomelcitinib Achieves Over 70% PASI-90 Response in Chinese Psoriasis Patients https://pharmadog.xyz/news/626487 pharmadog en 2026-11-02T05:09:00.000Z BridgeBio eyes first FDA approval for limb-girdle muscular dystrophy therapy https://pharmadog.xyz/news/629639 pharmadog en 2026-11-02T05:00:00.000Z FDA warns against Once Upon a Farm Tractor Wheels toddler bars due to choking risk https://pharmadog.xyz/news/629302 pharmadog en 2026-11-02T05:00:00.000Z Early Alert: B. Braun Medical Inc. Removes Streamline Bloodline Set for Dialog+ https://pharmadog.xyz/news/629609 pharmadog en 2026-11-02T00:00:00.000Z Study finds patient agreement forms match knowledge surveys, urging greater transparency in FDA’s mifepristone REMS https://pharmadog.xyz/news/629105 pharmadog en 2026-11-02T00:00:00.000Z Australian regulator opens consultation on clinical trial data sharing and ICH GCP guidance https://pharmadog.xyz/news/630221 pharmadog en 2026-11-02T00:00:00.000Z FDA issues final guidance on potency standards for cell and gene therapy developers https://pharmadog.xyz/news/629106 pharmadog en 2026-11-02T00:00:00.000Z FDA approves generic lenacapavir for low-income markets; EMA to review Lundbeck's Deanxit over safety concerns